acth

  1. forestglip

    Adrenocorticotropic hormone (ACTH) response in ME/CFS

    There's been some discussion of ACTH response recently, so it seemed like a good idea to see all the findings together. Thanks to members who already posted and linked some of these papers. I found some more through PubMed and Google Scholar. I'm not sure if I found all of the studies that...
  2. forestglip

    Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome, 2005, Gaab et al

    Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome Gaab, Jens; Rohleder, Nicolas; Heitz, Vera; Engert, Veronika; Schad, Tanja; Schürmeyer, Thomas H.; Ehlert, Ulrike OBJECTIVE It has been suggested that a hypofunctional...
  3. forestglip

    Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome, 2004, Gaab et al

    Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome Gaab, Jens; Engert, Veronika; Heitz, Vera; Schad, Tanja; Schürmeyer, Thomas H; Ehlert, Ulrike Objective Subtle dysregulations of the...
  4. forestglip

    Hypothalamic-Pituitary-Adrenal Axis Reactivity in [CFS] and Health Under Psychological, Physiological, and Pharmacological Stimulation, 2002, Gaab+

    Hypothalamic-Pituitary-Adrenal Axis Reactivity in Chronic Fatigue Syndrome and Health Under Psychological, Physiological, and Pharmacological Stimulation Jens Gaab, Dominik Hüster, Renate Peisen, Veronika Engert, Vera Heitz, Tanja Schad, Thomas H. Schürmeyer, Ulrike Ehlert Abstract Subtle...
  5. forestglip

    Hypothalamo-Pituitary-Adrenal Axis Dysfunction in Chronic Fatigue Syndrome, and the Effects of Low-Dose Hydrocortisone Therapy, 2001, Cleare et al

    Hypothalamo-Pituitary-Adrenal Axis Dysfunction in Chronic Fatigue Syndrome, and the Effects of Low-Dose Hydrocortisone Therapy Cleare, A. J.; Miell, J.; Heap, E.; Sookdeo, S.; Young, L.; Malhi, G. S.; O’Keane, V. Abstract These neuroendocrine studies were part of a series of studies testing...
  6. forestglip

    Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome, 2000, Moorkens et al

    Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome Moorkens, Greta; Berwaerts, Joris; Wynants, Herlindis; Abs, Roger Objective Previous studies have revealed that hormonal disturbances may accompany the chronic fatigue syndrome (CFS). Changes...
  7. forestglip

    Desmopressin augments pituitary–adrenal responsivity to [CRH] in subjects with [CFS] and in healthy volunteers, 1999, Scott et al

    Desmopressin augments pituitary–adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers Scott, Lucinda V; Medbak, Sami; Dinan, Timothy G Background Corticotopin-releasing hormone (CRH) and vasopressin (VP) are the two...
  8. forestglip

    Naloxone-mediated activation of the hypothalamic–pituitary–adrenal axis in chronic fatigue syndrome, 1998, Scott et al

    Naloxone-mediated activation of the hypothalamic–pituitary–adrenal axis in chronic fatigue syndrome L.V. Scott, F. Burnett, S. Medbak, T.G. Dinan Background Opioidergic pathways have an inhibitory regulatory influence on the hypothalamic–pituitary–adrenal axis (HPA) in man. Previous studies...
  9. forestglip

    Blunted adrenocorticotropin and Cortisol responses to corticotropin‐releasing hormone stimulation in chronic fatigue syndrome, 1998, Scott et al

    Blunted adrenocorticotropin and Cortisol responses to corticotropin‐releasing hormone stimulation in chronic fatigue syndrome Scott, L. V.; Medbak, S.; Dinan, T. G. Abstract Hyperfunctioning of the pituitary‐adrenal axis has been suggested as the pathophysiological basis for chronic fatigue...
  10. forestglip

    Thesis Neuroendocrine Alterations in Chronic Fatigue Syndrome, Majeed, 1996

    Neuroendocrine Alterations in Chronic Fatigue Syndrome Tahir Majeed Abstract Chronic fatigue syndrome (CFS) is an illness that occurs worldwide. Over the years the syndrome has had various labels, ranging from the Victorian one of neurasthenia to the putative neurological diagnosis of benign...
  11. chillier

    Blunted serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome, 1997, Dinan et al

    Blunted serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome T G Dinan, T Majeed, E Lavelle, L V Scott, C Berti, P Behan We examined 5HT1a-mediated ACTH release in patients with chronic fatigue syndrome (CFS) using a between-subjects design...
  12. forestglip

    Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome, 1995, Bearn et al

    Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome Bearn, Jenny; Allain, Theresa; Coskeran, Patsy; Munro, Neil; Butler, Joan; McGregor, Alan; Wessely, Simon Abstract Chronic fatigue syndrome (CFS) is a disorder characterized by severe...
  13. ScoutB

    Diurnal Variation of Adrenocortical Activity in Chronic Fatigue Syndrome, 1998, MacHale et al

    Diurnal Variation of Adrenocortical Activity in Chronic Fatigue Syndrome (Note: old paper) Abstract Baseline morning and evening serum cortisol and ACTH concentrations, and diurnal changes in hormone levels, were measured in 30 patients with chronic fatigue syndrome (CFS) but without...
  14. ScoutB

    Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome, 2000, Moorkens et al

    Characterization of pituitary function with emphasis on [Growth Hormone] secretion in the chronic fatigue syndrome Abstract OBJECTIVE Previous studies have revealed that hormonal disturbances may accompany the chronic fatigue syndrome (CFS). Changes in the secretion of the pituitary–adrenal...
  15. ScoutB

    Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome, 1991, Demitrack et al

    Evidence for Impaired Activation of the Hypothalamic-Pituitary-Adrenal Axis in Patients with Chronic Fatigue Syndrome Abstract Chronic fatigue syndrome is characterized by persistent or relapsing debilitating fatigue for at least 6 months in the absence of a medical diagnosis that would...
  16. forestglip

    Neuroendocrine signature of ME/CFS: Meta-analytic evidence for bioactive cortisol deficit and exaggerated feedback sensitivity, 2026, Woo et al

    Neuroendocrine signature of ME/CFS: Meta-analytic evidence for bioactive cortisol deficit and exaggerated feedback sensitivity Abstract Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a major clinical challenge as a complex multisystemic disorder with no well-established...
  17. Hutan

    Abnormalities in response to vasopressin infusion in chronic fatigue syndrome, 2001, Altemus et al

    2001 paper Several neuroendocrine studies have suggested hypoactivation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. One possible determinant of this neuroendocrine abnormality, as well as the primary symptom of fatigue, is reduced hypothalamic secretion of...
  18. SNT Gatchaman

    Salivary cortisol in long COVID: a marker of broader stress system and circadian rhythm dysregulation, 2026, Camici et al.

    Salivary cortisol in long COVID: a marker of broader stress system and circadian rhythm dysregulation INTRODUCTION Long COVID (LC) has been associated with hypothalamic–pituitary–adrenal (HPA) axis dysfunction, although findings from blood cortisol measurements remain inconsistent. We...
  19. forestglip

    927 – Hormonal Dysregulation in Long COVID: Exploring the Salivary Cortisol Profile, 2025, Camici et al

    927 – Hormonal Dysregulation in Long COVID: Exploring the Salivary Cortisol Profile Marta Camici, Marta Franco, Lorenzo Talamanca, Manuela Petino, Jessica Paulicelli, Liliana Scarnecchia, Alessandra Vergori, Stefano Curcio, Roberto Baldelli, Paolo Zuppi, Andrea Antinori [Line breaks added]...
  20. SNT Gatchaman

    Low growth hormone secretion associated with post-acute sequelae SARS-CoV-2 infection PASC neurologic symptoms: A case-control pilot study,2023,Wright

    Low growth hormone secretion associated with post-acute sequelae SARS-CoV-2 infection PASC neurologic symptoms: A case-control pilot study Wright; Pyles; Sheffield-Moore; Deer; Randolph; McGovern; Danesi; Gilkison; Ward; Vargas; Armstrong; Lindsay; Zaidan; Seashore; Wexler; Masel; Urban...
Back
Top Bottom